Does premature luteinization or early surge of LH impair cycle outcome? Report of two successful outcomes

Journal of Assisted Reproduction and Genetics

Volumn 26, Issue 2-3, 2009, Pages 159-163

  Sönmezer, Murat ^a   Pelin Cil, Aylin ^b   Atabekoğlu, Cem ^a   Özkavukçu, Sinan ^a   Özmen, Batuhan ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Embryo quality; Implantation; Oocyte quality; Premature luteinization; Progesterone

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CASE REPORT; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LUTEINIZATION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; METAPHASE; OOCYTE; OUTCOME ASSESSMENT; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY; LUTEINIZATION; LUTEINIZING HORMONE; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; TIME FACTORS; TREATMENT OUTCOME;

EID: 62449127803     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-009-9299-5     Document Type: Article

References (18)

1. TH Lee YH Lin KM Seow JL Hwang CR Tzeng YS Yang 2008 Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: A randomized trial Fertil Steril. 90 113 20 10.1016/j.fertnstert.2007.06.029
2. JB Engel M Ludwig R Felberbaum C Albano P Devroey K Diedrich 2002 Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: A suitable approach to "friendly IVF"? Hum Reprod. 17 2022 6 10.1093/humrep/17.8.2022
3. F Olivennes J Belaisch-Allart JC Emperaire H Dechaud S Alvarez L Moreau B Nicollet JR Zorn P Bouchard R Frydman 2000 Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin) Fertil Steril. 73 314 20 10.1016/S0015-0282(99) 00524-5
4. CB Lambalk A Leader F Olivennes MR Fluker AN Andersen J Ingerslev Y Khalaf C Avril J Belaisch-Allart R Roulier 2006 Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial Hum Reprod. 21 632 9 10.1093/humrep/dei386
5. Ganirelix dose finding study group 1998 A double blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®) Hum Reprod 13 3023 31 10.1093/humrep/13.11. 3023
6. European and Middle East Orgalutran Study Group 2001 Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum Reprod 16 644 51 10.1093/humrep/16.4.644
7. DL Cassidenti MV Sauer RJ Paulson EC Ditkoff J Rivier SS Yen RA Lobo 1991 Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report Am J Obstet Gynecol. 165 1806 10
8. R Frydman C Cornel D de Ziegler J Taieb IM Spitz P Bouchard 1991 Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation Fertil Steril. 56 923 7
9. MAB Melo M Meseguer N Garrido E Bosch A Pellicer J Remohí 2006 The significance of premature luteinization in an oocyte-donation programme Hum Reprod. 21 1503 7 10.1093/humrep/dei474
10. SG Hillier 1994 Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis Hum Reprod. 9 188 91
11. UD Gordon RF Harrison M Fawzy B Hennelly AC Gordon 2001 A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome Fertil Steril. 75 324 31 10.1016/S0015-0282(00) 01701-5
12. JA Huirne AC van Loenen R Schats J McDonnell PG Hompes J Schoemaker R Homburg CB Lambalk 2004 Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels Hum Reprod. 19 2206 15 10.1093/humrep/deh357
13. RS Legro BA Ary RJ Paulson FZ Stanczyk MV Sauer 1993 Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization Hum Reprod. 8 1506 11
14. E Bosch I Valencia E Escudero J Crespo C Simón J Remohí A Pellicer 2003 Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Fertil Steril. 80 1444 9 10.1016/j.fertnstert.2003.07.002
15. R Fanchin C Righini F Olivennes J Taieb D de Ziegler R Frydman 1999 Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation Fertil Steril. 71 174 81 10.1016/S0015-0282(98) 00410-5
16. R Fanchin C Righini JM Ayoubi F Olivennes D de Ziegler R Frydman 2000 New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer Fertil Steril. 74 274 81 10.1016/S0015-0282(00) 00643-9
17. A Allegra A Marino F Coffaro P Scaglione F Sammartano G Rizza A Volpes 2007 GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles, A prospective randomized trial Hum Reprod. 22 101 8 10.1093/humrep/del337
18. IE Messinis D Loutradis E Domali CP Kotsovassilis L Papastergiopoulou A Kallitsaris P Drakakis K Dafopoulos S Milingos 2005 Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment Hum Reprod. 20 3192 7 10.1093/humrep/dei210